Profile
Full Name
Armata Pharmaceuticals, Inc.Ticker Symbol
ARMPExchange
NYSE AmericanSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 20, 1994Indexes
Not includedWebsite
http://www.armatapharma.comEmployees
60Key Details
Price
$1.15(-0.86%)
Market cap
$41.61M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.89(+53.40% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Armata Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Dec 19, 24 HC Wainwright & Co.
BuyNov 14, 24 HC Wainwright & Co.
BuyNov 12, 24 HC Wainwright & Co.
BuyAug 15, 24 HC Wainwright & Co.
BuyJul 11, 24 HC Wainwright & Co.
BuyMay 8, 24 HC Wainwright & Co.
BuyMar 22, 24 HC Wainwright & Co.
BuyAug 14, 23 HC Wainwright & Co.
BuyMay 12, 23 HC Wainwright & Co.
BuyMar 17, 23 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Armata Pharmaceuticals?
- Does Armata Pharmaceuticals pay dividends?
- What sector is Armata Pharmaceuticals in?
- What industry is Armata Pharmaceuticals in?
- What country is Armata Pharmaceuticals based in?
- When did Armata Pharmaceuticals go public?
- Is Armata Pharmaceuticals in the S&P 500?
- Is Armata Pharmaceuticals in the NASDAQ 100?
- Is Armata Pharmaceuticals in the Dow Jones?
- When was Armata Pharmaceuticals's last earnings report?
- When does Armata Pharmaceuticals report earnings?
- Should I buy Armata Pharmaceuticals stock now?
What is the ticker symbol for Armata Pharmaceuticals?
The ticker symbol for Armata Pharmaceuticals is NYSE American:ARMP
Does Armata Pharmaceuticals pay dividends?
No, Armata Pharmaceuticals does not pay dividends
What sector is Armata Pharmaceuticals in?
Armata Pharmaceuticals is in the Healthcare sector
What industry is Armata Pharmaceuticals in?
Armata Pharmaceuticals is in the Biotechnology industry
What country is Armata Pharmaceuticals based in?
Armata Pharmaceuticals is headquartered in United States
When did Armata Pharmaceuticals go public?
Armata Pharmaceuticals's initial public offering (IPO) was on May 20, 1994
Is Armata Pharmaceuticals in the S&P 500?
No, Armata Pharmaceuticals is not included in the S&P 500 index
Is Armata Pharmaceuticals in the NASDAQ 100?
No, Armata Pharmaceuticals is not included in the NASDAQ 100 index
Is Armata Pharmaceuticals in the Dow Jones?
No, Armata Pharmaceuticals is not included in the Dow Jones index
When was Armata Pharmaceuticals's last earnings report?
Armata Pharmaceuticals's most recent earnings report was on Mar 20, 2025
When does Armata Pharmaceuticals report earnings?
The next expected earnings date for Armata Pharmaceuticals is May 7, 2025
Should I buy Armata Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions